Jump to content

  • Log in with Facebook Log in with Twitter Log in with Windows Live Log In with Google      Sign In   
  • Create Account

Submit your paper to J Biol Methods today!
Photo
- - - - -

Moving toward a new kind of medicine

antisense n=1 clinical trial rare disease

  • Please log in to reply
1 reply to this topic

#1 Jon Moulton

Jon Moulton

    Veteran

  • Active Members
  • PipPipPipPipPipPipPipPipPipPip
  • 164 posts
3
Neutral

Posted 01 October 2021 - 08:27 AM

Preparing n-of-1 Antisense Oligonucleotide Treatments for Rare Neurological Diseases in Europe: Genetic, Regulatory, and Ethical Perspectives. https://pubmed.ncbi....h.gov/34591693/


Jon D. Moulton
Gene Tools, LLC
www.gene-tools.com

#2 Jon Moulton

Jon Moulton

    Veteran

  • Active Members
  • PipPipPipPipPipPipPipPipPipPip
  • 164 posts
3
Neutral

Posted 29 November 2021 - 09:51 AM

Jon - I've edited out some obvious spam that you had quoted here. The poster had probably edited their response to include links. Bob.

 

 

Are you really suggesting psychotherpay as an alternative treatment for the diseases discussed in the paper I cited?  By what mechanism do you propose that psychotherpay might alter the clinical course of genetic conditions like Duchenne muscular dystrophy or spinal muscle atrophy?


Jon D. Moulton
Gene Tools, LLC
www.gene-tools.com





Also tagged with one or more of these keywords: antisense, n=1, clinical trial, rare disease

Home - About - Terms of Service - Privacy - Contact Us

©1999-2013 Protocol Online, All rights reserved.